FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group pur.
Federal Trade Commission sues largest drug middlemen for ... - CNN
Sep 20, 2024 · The agency alleges that CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx and their affiliated group purchasing organizations created a system that...
Express Scripts® Further Advances Transparency and …
Apr 13, 2023 · Express Scripts is introducing a new and innovative solution, the Copay Assurance plan, which caps consumer out-of-pocket costs for prescription drugs under a client's prescription drug benefit.
Express Scripts sues FTC over drug pricing report | Reuters
Sep 17, 2024 · Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's conclusion that the prescription...
Express Scripts conspired to overcharge pharmacies, class ...
Oct 20 (Reuters) - A group of pharmacies has filed a proposed class action lawsuit accusing Cigna Group's (CI.N) pharmacy benefit manager unit Express Scripts Inc of conspiring with another...
Drug middlemen illegally drive up the cost of insulin, FTC says
Sep 20, 2024 · The companies — CVS-owned Caremark Rx, Cigna Group's Express Scripts and UnitedHealth Group's Optum Rx — acted in ways that stifled industry competition for insulin drugs, including by using...
Federal regulators sue St. Louis-based Express Scripts | STLPR
Sep 30, 2024 · The Federal Trade Commission on Sept. 20 filed a complaint against pharmacy benefit manager Express Scripts, alleging it and two other companies, OptumRx and Caremark, have artificially inflated insulin prices at the expense of patients.
Federal Trade Commission accuses three drug middlemen of …
Sep 21, 2024 · The FTC accused the "Big Three" pharmacy benefit managers (PBMs) — UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts — of "engaging in anticompetitive and unfair...
Express Scripts Sues FTC Over Drug Pricing Report - U.S. News
Sep 17, 2024 · NEW YORK (Reuters) -Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's conclusion...
Express Scripts Adds Three Biosimilars to Largest Formulary to …
Jul 10, 2023 · The biosimilar Amjevita (Amgen), citrate-free, low concentration formulation, is currently preferred on the Express Scripts NPF and the National Preferred Flex Formulary for 2023.
- Some results have been removed